APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 42 filers reported holding APREA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $11,000 | -75.6% | 16,843 | -72.1% | 0.00% | – |
Q2 2022 | $45,000 | +28.6% | 60,383 | +224.5% | 0.00% | – |
Q1 2022 | $35,000 | -97.9% | 18,610 | -94.2% | 0.00% | -100.0% |
Q1 2021 | $1,649,000 | +111.1% | 323,362 | +103.6% | 0.00% | +100.0% |
Q4 2020 | $781,000 | – | 158,814 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 1,259,662 | $6,437,000 | 2.66% |
COASTAL INVESTMENT MANAGEMENT, L.P. | 41,965 | $214,000 | 0.30% |
Redmile Group, LLC | 694,918 | $3,551,000 | 0.06% |
Quantamental Technologies LLC | 13,752 | $70,000 | 0.05% |
KENNEDY CAPITAL MANAGEMENT LLC | 342,486 | $1,750,000 | 0.04% |
PDT Partners, LLC | 87,734 | $448,000 | 0.03% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 75,000 | $383,000 | 0.01% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 49,100 | $251,000 | 0.01% |
NEXT Financial Group, Inc | 11,347 | $58,000 | 0.01% |
Sugarloaf Wealth Management, LLC | 1,500 | $8,000 | 0.00% |